HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Geeta Vanage Selected Research

1- biphenyl- 4- yl- 2- (4- nitrophenoxy)ethanone

12/2010Novel biphenyl compound, VMNS2e, ameliorates streptozotocin-induced diabetic nephropathy in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Geeta Vanage Research Topics

Disease

3Body Weight (Weight, Body)
07/2013 - 08/2010
1Tuberculosis (Tuberculoses)
03/2020
1Diabetes Mellitus
03/2020
1Rheumatoid Arthritis
03/2020
1Neuroinflammatory Diseases
01/2019
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Fetal Resorption
01/2016
1Malaria
01/2016
1Dyslipidemias (Dyslipidemia)
06/2015
1Aneuploidy (Aneuploid)
03/2012
1Brucellosis (Malta Fever)
02/2011
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2010
1Chromosome Aberrations (Chromosome Abnormalities)
08/2010
1Herpes Zoster
11/2009

Drug/Important Bio-Agent (IBA)

1GoldIBA
03/2020
1Biomarkers (Surrogate Marker)IBA
01/2019
1PhloretinIBA
01/2019
1AntioxidantsIBA
01/2019
1artemisinin (artemisinine)IBA
01/2016
1ArtesunateIBA
01/2016
1Clindamycin (Cleocin)FDA LinkGeneric
01/2016
1saroglitazarIBA
06/2015
1Testosterone (Sustanon)FDA Link
07/2013
1DNA AdductsIBA
03/2012
1Doxycycline (Periostat)FDA LinkGeneric
02/2011
1Pharmaceutical PreparationsIBA
02/2011
1Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
12/2010
1diphenyl (biphenyl)IBA
12/2010
11- biphenyl- 4- yl- 2- (4- nitrophenoxy)ethanoneIBA
12/2010
1Blood Glucose (Blood Sugar)IBA
12/2010
1Streptozocin (Streptozotocin)FDA Link
12/2010
1CurcuminIBA
08/2010
1methylmethacrylate-methacrylic acid copolymerIBA
08/2010
1Cadherins (E-Cadherin)IBA
11/2009
1Connexin 43 (Connexin43)IBA
11/2009

Therapy/Procedure

1Therapeutics
01/2016